<DOC>
	<DOCNO>NCT00181818</DOCNO>
	<brief_summary>The purpose study test efficacy safety bupropion SR smoker hospitalize acute cardiovascular disease .</brief_summary>
	<brief_title>Bupropion Hospitalized Smokers With Acute Cardiovascular Disease</brief_title>
	<detailed_description>Each year , 2 million Americans hospitalize myocardial infarction ( MI ) unstable angina pectoris , two acute potentially fatal manifestation coronary heart disease ( CHD ) . Smoking cessation highly cost-effective universally recommend approximately 20 % patient smoke . Hospitalization acute CHD excellent time initiate smoking cessation hospitalization require temporary tobacco abstinence time illness increase smoker â€™ motivation quit . Unfortunately , least 40 % smoker fail quit even optimal cognitive-behavioral counseling intervention begin hospital continue discharge . More powerful intervention strategy need . Adding pharmacotherapy behavioral counseling , standard practice outpatient , test set concern safety nicotine replacement MI . Sustained release ( SR ) bupropion ( Zyban , Wellbutrin SR ) non-nicotine antidepressant drug recently prove effective smoking cessation . It appear safe cardiac patient may additional benefit prevent post-MI depression , independent predictor mortality . This study test efficacy safety bupropion SR smoking cessation adult smoker hospitalize MI unstable angina . To , conduct five-site randomized double-blind placebo-controlled trial determine whether bupropion SR , initiate hospital continue 12 week , effective safe add comprehensive cognitive-behavioral smoking counseling . The primary outcome measure biochemically-confirmed 7-day point prevalence tobacco abstinence 1 year follow-up . Principal secondary outcome measure biochemically-confirmed 7-day point-prevalence end-of-treatment ( 12 week ) . Secondary aim test whether bupropion SR delay time smoke relapse , reduce CHD morbidity depressive symptom , improve health-related quality life 1 year follow-up .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>&gt; 18 year old , smoke &gt; 1 cigarette past month , admit hospital diagnosis acute cardiovascular disease ( see ) expect hospital stay &gt; 24 hour . Eligible admission diagnosis include ( 1 ) acute ischemic coronary heart disease ( MI unstable angina ) , ( 2 ) coronary artery bypass graft surgery , ( 3 ) cardiovascular condition ( congestive heart failure , cardiac arrhythmia , valvular heart disease , atherosclerotic disease aorta , carotid , renal peripheral artery ) subject document coronary artery disease . willing consider smoke cessation discharge , contraindication bupropion ( seizure disorder , monoamine oxidase inhibitor use , history anorexia nervosa bulimia , bupropion allergy ) condition increase risk seizure ( e.g. , serious head trauma loss consciousness uncontrolled hypertension ( BP &gt; 160/100 ) hospital heavy alcohol use ( &gt; 3 drinks/day ) binge drinking ( &gt; 6 drink male &gt; 5 drink female ) least monthly renal insufficiency ( serum creatinine &gt; 2.0 mg/dl ) , severe hepatic disease severe depression severe cognitive impairment psychosis life expectancy &lt; 12 month , illegal drug use past 6 month bupropion use past month nonEnglish speak telephone residence outside defined geographic area .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Smoking cessation</keyword>
	<keyword>Bupropion SR</keyword>
	<keyword>Hospital intervention</keyword>
	<keyword>Myocardial infarction</keyword>
	<keyword>Unstable angina</keyword>
</DOC>